| The course of untreated Mycobacterium kansasii disease. | |
| | |
MedLine Citation:
|
PMID: 1124888 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Four patients with Mycobacterium kansaii pulmonary infection were followed without treatment for 10 to 14 years after diagnosis. Although spontaneous resolution of active disease occurred 5 years after diagnosis in one patient, slowly progressive disease in the absence of significant symptoms was documented in 3 patients during a 12-to-14-year follow-up period. Administration of antituberculous drugs resulted in rapid resolution of signs of active disease in these patients. These observations added to our limited knowledge of the natural history of M. kansasii disease. |
| | |
Authors:
|
P B Francis; S J Jay; W G Johanson |
Related Documents
:
|
20002758 - Associated conditions and clinical significance of awake bruxism. 10436098 - Increased thromboxane biosynthesis is associated with poststroke dementia. 11117548 - The selective muscarinic m1 agonist af102b decreases levels of total abeta in cerebrosp... 8845698 - Quantified electroencephalographic correlates of relative frontal or parietal hypoperfu... 16461328 - Breakthrough fungemia caused by fluconazole-resistant candida albicans with decreased s... 21071108 - Availability of a newly devised ambulatory urodynamics monitoring system based on perso... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The American review of respiratory disease Volume: 111 ISSN: 0003-0805 ISO Abbreviation: Am. Rev. Respir. Dis. Publication Date: 1975 Apr |
Date Detail:
|
Created Date: 1975-07-07 Completed Date: 1975-07-07 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0370523 Medline TA: Am Rev Respir Dis Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 477-87 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Ethambutol / therapeutic use Female Follow-Up Studies Forced Expiratory Volume Humans Isoniazid / therapeutic use Lung Diseases* / microbiology, radiography Male Middle Aged Mycobacterium / isolation & purification Mycobacterium Infections* / microbiology, radiography Rifampin / therapeutic use Vital Capacity |
| Chemical | |
Reg. No./Substance:
|
13292-46-1/Rifampin; 54-85-3/Isoniazid; 74-55-5/Ethambutol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Suppression of lymphocyte function by products derived from cigarette smoke.
Next Document: Tension pleural effusion. A delayed complication of pneumothorax therapy in tuberculosis.